Alon Lazarus

Dr. Alon Lazarus is a Biotech Investment Manager for Arkin Holdings’ Pharma Division. He is a member of the Board of several of its pharmaceutical companies, including Keros Therapeutics, Lutris Pharma, Redpin Therapeutics, and Explore Bio.

Prior to joining Arkin, Dr. Lazarus worked for the Healthcare Business Development Department of Yissum—the Research & Development arm of the Hebrew University and as an analyst for the University’s Integra Holdings. Alon earned both a Ph.D. in Molecular Biology and an MBA from the Hebrew University of Jerusalem in Israel.